• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对埃博拉病毒 VP35 的 RNA 适体的开发。

Development of RNA aptamers targeting Ebola virus VP35.

机构信息

Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri 63110, United States.

出版信息

Biochemistry. 2013 Nov 26;52(47):8406-19. doi: 10.1021/bi400704d. Epub 2013 Nov 14.

DOI:10.1021/bi400704d
PMID:24067086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3909728/
Abstract

Viral protein 35 (VP35), encoded by filoviruses, is a multifunctional dsRNA binding protein that plays important roles in viral replication, innate immune evasion, and pathogenesis. The multifunctional nature of these proteins also presents opportunities to develop countermeasures that target distinct functional regions. However, functional validation and the establishment of therapeutic approaches toward such multifunctional proteins, particularly for nonenzymatic targets, are often challenging. Our previous work on filoviral VP35 proteins defined conserved basic residues located within its C-terminal dsRNA binding interferon (IFN) inhibitory domain (IID) as important for VP35 mediated IFN antagonism and viral polymerase cofactor functions. In the current study, we used a combination of structural and functional data to determine regions of Ebola virus (EBOV) VP35 (eVP35) to target for aptamer selection using SELEX. Select aptamers, representing, two distinct classes, were further characterized based on their interaction properties to eVP35 IID. These results revealed that these aptamers bind to distinct regions of eVP35 IID with high affinity (10-50 nM) and specificity. These aptamers can compete with dsRNA for binding to eVP35 and disrupt the eVP35-nucleoprotein (NP) interaction. Consistent with the ability to antagonize the eVP35-NP interaction, select aptamers can inhibit the function of the EBOV polymerase complex reconstituted by the expression of select viral proteins. Taken together, our results support the identification of two aptamers that bind filoviral VP35 proteins with high affinity and specificity and have the capacity to potentially function as filoviral VP35 protein inhibitors.

摘要

病毒蛋白 35(VP35),由丝状病毒编码,是一种多功能的 dsRNA 结合蛋白,在病毒复制、先天免疫逃避和发病机制中发挥重要作用。这些蛋白质的多功能性质也为开发针对不同功能区域的对策提供了机会。然而,针对这些多功能蛋白质(特别是非酶靶标)进行功能验证和建立治疗方法通常具有挑战性。我们之前关于丝状病毒 VP35 蛋白的工作确定了位于其 C 端 dsRNA 结合干扰素(IFN)抑制域(IID)内的保守碱性残基对 VP35 介导的 IFN 拮抗和病毒聚合酶辅助因子功能很重要。在当前的研究中,我们使用结构和功能数据的组合来确定埃博拉病毒(EBOV)VP35(eVP35)的区域,以使用 SELEX 进行适体选择。选择的适体代表两个不同的类别,进一步根据它们与 eVP35 IID 的相互作用特性进行了表征。这些结果表明,这些适体以高亲和力(10-50 nM)和特异性结合到 eVP35 IID 的不同区域。这些适体可以与 dsRNA 竞争结合 eVP35 并破坏 eVP35-核蛋白(NP)相互作用。与拮抗 eVP35-NP 相互作用的能力一致,选择的适体可以抑制通过表达选择的病毒蛋白重新构成的 EBOV 聚合酶复合物的功能。总之,我们的结果支持鉴定两种与丝状病毒 VP35 蛋白具有高亲和力和特异性的适体,并且有可能作为丝状病毒 VP35 蛋白抑制剂发挥作用。

相似文献

1
Development of RNA aptamers targeting Ebola virus VP35.针对埃博拉病毒 VP35 的 RNA 适体的开发。
Biochemistry. 2013 Nov 26;52(47):8406-19. doi: 10.1021/bi400704d. Epub 2013 Nov 14.
2
Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.埃博拉病毒 VP35 蛋白中的基本残基是其病毒聚合酶辅助因子功能所必需的。
J Virol. 2010 Oct;84(20):10581-91. doi: 10.1128/JVI.00925-10. Epub 2010 Aug 4.
3
In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activity.计算机衍生的小分子与丝状病毒 VP35 蛋白结合并抑制其聚合酶辅因子活性。
J Mol Biol. 2014 May 15;426(10):2045-58. doi: 10.1016/j.jmb.2014.01.010. Epub 2014 Feb 1.
4
Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay.通过一种基于新型荧光的检测方法鉴定杨梅素为埃博拉病毒VP35-双链RNA相互作用抑制剂。
Biochemistry. 2018 Nov 6;57(44):6367-6378. doi: 10.1021/acs.biochem.8b00892. Epub 2018 Oct 22.
5
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.洋蓟素通过对抗VP35对β干扰素产生的抑制作用来阻断埃博拉病毒复制。
Antiviral Res. 2022 Feb;198:105251. doi: 10.1016/j.antiviral.2022.105251. Epub 2022 Jan 20.
6
Structure of the Ebola VP35 interferon inhibitory domain.埃博拉病毒VP35干扰素抑制结构域的结构
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):411-6. doi: 10.1073/pnas.0807854106. Epub 2009 Jan 2.
7
Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.马尔堡病毒 VP35 介导的免疫逃避机制的结构基础。
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20661-6. doi: 10.1073/pnas.1213559109. Epub 2012 Nov 26.
8
Exploration micromechanism of VP35 IID interaction and recognition dsRNA: A molecular dynamics simulation.VP35 IID相互作用与识别双链RNA的微观机制探索:分子动力学模拟
Proteins. 2017 Jun;85(6):1008-1023. doi: 10.1002/prot.25269. Epub 2017 Mar 7.
9
Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.埃博拉病毒 VP35 蛋白与 RIG-I 激活剂 PACT 之间的相互拮抗决定了感染结果。
Cell Host Microbe. 2013 Jul 17;14(1):74-84. doi: 10.1016/j.chom.2013.06.010.
10
Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain.埃博拉病毒 VP35 IFN 抑制结构域疏水区功能的重要性。
Viruses. 2021 Nov 20;13(11):2316. doi: 10.3390/v13112316.

引用本文的文献

1
Oligonucleotide-Based Modulation of Macrophage Polarization: Emerging Strategies in Immunotherapy.基于寡核苷酸的巨噬细胞极化调控:免疫治疗中的新兴策略
Immun Inflamm Dis. 2025 May;13(5):e70200. doi: 10.1002/iid3.70200.
2
Aptamers: precision tools for diagnosing and treating infectious diseases.适配体:诊断和治疗传染病的精准工具。
Front Cell Infect Microbiol. 2024 Sep 25;14:1402932. doi: 10.3389/fcimb.2024.1402932. eCollection 2024.
3
RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens.基于 RNA 的疫苗和针对细胞内病原体的治疗方法。

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.埃博拉病毒 VP35 蛋白与 RIG-I 激活剂 PACT 之间的相互拮抗决定了感染结果。
Cell Host Microbe. 2013 Jul 17;14(1):74-84. doi: 10.1016/j.chom.2013.06.010.
3
Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.马尔堡病毒 VP35 介导的免疫逃避机制的结构基础。
Methods Mol Biol. 2024;2813:321-370. doi: 10.1007/978-1-0716-3890-3_21.
4
Aptamers targeting SARS-COV-2: a promising tool to fight against COVID-19.针对 SARS-COV-2 的适配体:抗击 COVID-19 的有前途工具。
Trends Biotechnol. 2023 Apr;41(4):528-544. doi: 10.1016/j.tibtech.2022.07.012. Epub 2022 Aug 1.
5
Applications in Which Aptamers Are Needed or Wanted in Diagnostics and Therapeutics.在诊断和治疗中需要或希望使用适体的应用。
Pharmaceuticals (Basel). 2022 Jun 1;15(6):693. doi: 10.3390/ph15060693.
6
Biodiagnostics in an era of global pandemics-From biosensing materials to data management.全球大流行时代的生物诊断——从生物传感材料到数据管理
View (Beijing). 2022 Mar;3(2):20200164. doi: 10.1002/VIW.20200164. Epub 2021 Jun 18.
7
Structural and Functional Aspects of Ebola Virus Proteins.埃博拉病毒蛋白的结构与功能方面
Pathogens. 2021 Oct 15;10(10):1330. doi: 10.3390/pathogens10101330.
8
Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy.病毒学中的适配体——诊断与治疗最新进展的综合综述
Pharmaceutics. 2021 Oct 9;13(10):1646. doi: 10.3390/pharmaceutics13101646.
9
Aptamers for Anti-Viral Therapeutics and Diagnostics.适体在抗病毒治疗和诊断中的应用
Int J Mol Sci. 2021 Apr 17;22(8):4168. doi: 10.3390/ijms22084168.
10
AptaNet as a deep learning approach for aptamer-protein interaction prediction.AptaNet 作为一种深度学习方法,用于适配体-蛋白质相互作用预测。
Sci Rep. 2021 Mar 16;11(1):6074. doi: 10.1038/s41598-021-85629-0.
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20661-6. doi: 10.1073/pnas.1213559109. Epub 2012 Nov 26.
4
Ebolavirus vaccines for humans and apes.埃博拉病毒人类和猿类疫苗。
Curr Opin Virol. 2012 Jun;2(3):324-9. doi: 10.1016/j.coviro.2012.04.003. Epub 2012 May 4.
5
RNA aptamers: a review of recent trends and applications.RNA 适体:近期趋势与应用综述。
Adv Biochem Eng Biotechnol. 2013;131:153-69. doi: 10.1007/10_2012_136.
6
Aptamers in virology: recent advances and challenges.病毒学中的适体:最新进展与挑战
Front Microbiol. 2012 Feb 8;3:29. doi: 10.3389/fmicb.2012.00029. eCollection 2012.
7
Discovery of an ebolavirus-like filovirus in europe.在欧洲发现一种类似埃博拉病毒的丝状病毒。
PLoS Pathog. 2011 Oct;7(10):e1002304. doi: 10.1371/journal.ppat.1002304. Epub 2011 Oct 20.
8
Advances in virus-like particle vaccines for filoviruses.病毒样颗粒疫苗在丝状病毒中的研究进展。
J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1053-9. doi: 10.1093/infdis/jir346.
9
Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway.埃博拉病毒蛋白通过与哺乳动物 RNA 干扰途径的直接相互作用来抑制小干扰 RNA 的作用。
J Virol. 2011 Mar;85(6):2512-23. doi: 10.1128/JVI.01160-10. Epub 2011 Jan 12.
10
Ebolavirus VP35 is a multifunctional virulence factor.埃博拉病毒 VP35 是一种多功能毒力因子。
Virulence. 2010 Nov-Dec;1(6):526-31. doi: 10.4161/viru.1.6.12984. Epub 2010 Nov 1.